---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-032680"
form_type: "8-K/A"
ticker: "SONM"
cik: "0001178697"
company_name: "DNA X, Inc."
filed_at: "2026-07-09T20:05:15+00:00"
generated_at: "2026-07-09T20:06:12.144226+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# DNA X raises $2.5M in Series B Preferred, cancels $3.1M debt to meet Nasdaq equity requirement

## Summary
- Sold 929,864 Series B Preferred shares for $2.5M cash and cancellation of $3.1M convertible note balance.
- Pro forma stockholders' equity as of July 9, 2026 is $3.798M, above Nasdaq's $2.5M minimum.
- Remaining 416,667 Series B shares expected to close by August 14, 2026.
- Company awaits Nasdaq formal determination of compliance with minimum equity rule.

## SEC filing metadata
- accession: 0001493152-26-032680
- form_type: 8-K/A
- ticker: SONM
- cik: 0001178697
- company_name: DNA X, Inc.
- filed_at: 2026-07-09T20:05:15+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01, 3.02, 3.03, 5.03
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1178697/000149315226032680/0001493152-26-032680-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1178697/000149315226032680/form8-ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-032680
- JSON: https://secwatch.observer/filing/0001493152-26-032680.json
- Plain text: https://secwatch.observer/filing/0001493152-26-032680.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.